Patent · US Active

Branched oligonucleotides

US11896669B2 · kind B2 · utility

5Cited by
77References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 4, 2020
Grant dateFeb 13, 2024
Priority date—
Expiry dateApr 6, 2042

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2310/52
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein are branched oligonucleotides exhibiting efficient and specific tissue distribution, cellular uptake, minimum immune response and off-target effects, without formulation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.